Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

cryptdin 26 Inhibitors

Cryptdin 26 inhibitors belong to a class of antimicrobial peptides known as cryptdins, which are produced primarily by Paneth cells in the intestinal epithelium. Cryptdin 26 is characterized by its distinctive structure, which typically includes a cationic charge and an amphipathic nature, allowing it to interact effectively with microbial membranes. The peptide plays a significant role in the innate immune response by targeting a variety of pathogens, including bacteria, fungi, and certain viruses. Its mechanism of action is largely based on its ability to disrupt microbial membranes, leading to increased permeability and eventual cell lysis. The specific amino acid composition and folding patterns of cryptdin 26 contribute to its membrane-active properties, enabling it to penetrate lipid bilayers and compromise the integrity of microbial cells.

Inhibitors of cryptdin 26 function by obstructing the peptide's ability to engage with its target membranes or by modifying its structure to reduce its efficacy. These inhibitors can act through various mechanisms, including competitive binding, which prevents cryptdin 26 from interacting with microbial surfaces. Additionally, some inhibitors may alter the conformational stability of the peptide, thereby diminishing its ability to adopt the necessary structural forms for effective membrane insertion. Investigating the interactions between cryptdin 26 and its inhibitors provides a deeper understanding of the dynamics governing antimicrobial peptide function. This exploration not only sheds light on the mechanisms of action and resistance but also enhances the understanding of host-microbe interactions, particularly within the gut environment. By analyzing these complex relationships, researchers can gain insights into the role of antimicrobial peptides in maintaining microbial balance and overall intestinal health.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$99.00
$335.00
$836.00
$2099.00
47
(3)

Daptomycin, a lipopeptide antibiotic, directly inhibits Defa26 by depolarizing bacterial cell membranes. This inhibition influences the innate immune response in mucosa and contributes to the defense response against extracellular pathogens.

Fusidic acid

6990-06-3sc-215065
1 g
$292.00
(0)

Fusidic acid, a steroidal antibiotic, directly inhibits Defa26 by interfering with bacterial protein synthesis. This inhibition modulates the innate immune response in mucosa and contributes to the defense response against extracellular pathogens.

Bacitracin

1405-87-4sc-252399
5 g
$87.00
1
(1)

Bacitracin, a cyclic polypeptide antibiotic, directly inhibits Defa26 by interfering with bacterial cell wall synthesis. This inhibition modulates the antimicrobial humoral immune response mediated by antimicrobial peptides, specifically targeting extracellular pathogens.

Polymyxin B Sulfate

1405-20-5sc-3544
500 mg
$62.00
8
(1)

Polymyxin B, a cyclic cationic polypeptide antibiotic, directly inhibits Defa26 by disrupting bacterial cell membranes. This inhibition influences the innate immune response in mucosa and contributes to the defense response against extracellular pathogens.